Ionis Pharmaceuticals, Inc. 8-K Report: Key Developments Revealed!
Based on the provided XML section of the financial report for Ionis Pharmaceuticals, Inc., here are the key pieces of information extracted:
- Entity Information:
- Company Name: Ionis Pharmaceuticals, Inc.
- CIK (Central Index Key): 0000874015
- State of Incorporation: Delaware (DE)
- SEC File Number: 000-19125
- IRS Employer Identification Number: 33-0336973
- Address: 2855 Gazelle Court, Carlsbad, CA 92010
- Contact Number: 760-931-9200
- Report Type and Date:
- Form Type: 8-K (a current report used to disclose major events that shareholders should know about)
- Filing Date: December 19, 2024
- Security Information:
- Class of Securities: Common Stock
- Par Value: $0.001
- Ticker Symbol: IONS
- Exchange: NASDAQ
- Reporting Period:
- Report Period Start Date: December 19, 2024
- Report Period End Date: December 19, 2024
Insights:
- The filing is a Form 8-K, indicating that there may be significant news or developments concerning Ionis Pharmaceuticals that are important for investors.
- The date of the report suggests it may contain information about a specific event or announcement made on that day.
- The common stock is listed on NASDAQ under the ticker symbol IONS, which provides insight into its market presence and trading activity.
This information is crucial for investors and stakeholders to understand the current status and potential developments surrounding Ionis Pharmaceuticals, Inc.